Ketil Sverdrup

Ketil Sverdrup is an accomplished finance professional with extensive experience in financial management, controlling, and strategic finance. Currently serving as Finance Director for Group Controlling at Ascendis Pharma since May 2021, Ketil is responsible for global standard cost pricing, inventory reporting, and optimizing global purchase order accrual processes. Prior to this role, Ketil held finance leadership positions at FOSS Analytical A/S, overseeing global finance operations for multiple R&D and production sites, and managed teams in finance operations, business support, and indirect procurement. Other notable roles include Finance Director at CMC Biologics A/S, where responsibilities included cash flow management and budgeting, and at Actavis and Alpharma, where Ketil directed finance activities for the WEMEA and EMEA regions, respectively. Ketil Sverdrup's academic background includes a Master of Science in Management Accounting from Copenhagen Business School and a Bachelor of Science in Finance from Nord-Trøndelag University College.